Year: 2019

PRINCETON, N.J., Dec. 02, 2019 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Clearway Energy”) today announced that it has commenced an underwritten public offering of 5,405,405 shares of its Class C common stock. Clearway Energy intends to use the net proceeds from the offering to acquire newly issued Class C units of Clearway Energy LLC (“Clearway LLC”).  Clearway Energy intends to cause Clearway LLC to use such proceeds to partially fund the acquisition of the 527 megawatt Carlsbad Energy Center from an affiliate of Global Infrastructure Partners III (“GIP”), pay transaction fees and expenses and use the balance of the proceeds, if any, for general corporate purposes.RBC Capital Markets, LLC will act as the sole book runner for the offering.A shelf registration statement (including a prospectus) relating to...

Paris, 02 December 2019, 10.15pmSummary of webcast with Key Opinion Leaders on masitinibPhase 3 results in severe asthma uncontrolled by oral corticosteroidsAB Science SA (NYSE Euronext – FR0010557264 – AB) is providing a summary of the live webcast held on 02 December with key opinion leaders on severe asthma uncontrolled by oral corticosteroids (OCS) and the role that masitinib may play in treating this disorder.The presentation of the webcast is available on the company’s website.A replay of the webcast is available at the following address: Webcast ReplayExperts’ opinionMasitinib is a first in class oral drug in severe asthma, selectively targeting mast cells. There is a strong scientific rationale to target mast cells in asthma and study AB07015 was the first positive large-scale study in severe asthma utilizing a drug...

Paris, 2 décembre 2019, 22h15Résumé de la conférence web avec les principaux leaders d’opinion autourdes résultats de la phase 3 du masitinib dans l’asthme sévèrenon contrôlé par les corticostéroïdes orauxAB Science SA (NYSE Euronext – FR0010557264 – AB) fournit le résumé de la conférence web du 2 décembre sur l’asthme sévère non contrôlé par les corticostéroïdes oraux avec les principaux leaders d’opinion de cette maladie et sur le rôle du masitinib comme possible traitement dans cette indication.La présentation de la conférence web est disponible sur le site internet d’AB Science.Un replay audio de la conférence est disponible à l’adresse suivante : Replay webcastOpinion des principaux leaders d’opinionLe masitinib est un médicament administré par voie orale et pionnier dans le traitement de l’asthme sévère, qui cible...

TORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Colliers International, leading global commercial real estate services and investment management firm (NASDAQ and TSX: CIGI), today announced its intention to build a market-leading presence across North Carolina by launching a new company-owned operation in Raleigh as a complement to its existing business in Charlotte. Colliers will not renew its license with its existing affiliate and will open new operations by the third quarter of 2020.J. Scott Adams, Colliers International Virginia | President will oversee the new operation in Raleigh, including efforts to identify a proven business leader and recruiting high-quality professionals in capital markets, leasing and property management.“Colliers enjoys a strong position in the Southeast and is deeply committed to North Carolina, one of...

MADISON, Wis., Dec. 02, 2019 (GLOBE NEWSWIRE) — The Madison Covered Call and Equity Strategy Fund (NYSE:MCN) (the “Fund”) declares its quarterly dividend of $0.18/share. The dividends will be payable December 30, 2019 to shareholders of record on December 17, 2019. The ex-dividend date will be December 16, 2019. If it is determined that a notification is required pursuant to Section 19(a) of the Investment Company Act of 1940, as amended, such notice will be posted to the Fund’s website after the close of business three business days before the payable date. If a distribution rate is largely comprised of sources other than income, it may not reflect Fund performance.The Fund’s objective is to achieve a high level of current income and current capital gains, with long-term capital appreciation as a secondary objective. The Fund intends...

 ACQUISITION OF FAIRFAX MEMORIAL PARK AND FUNERAL HOME;COMPANY MILESTONE TWO YEAR SCENARIO;WILLIAM (BILL) GOETZ JOINS AS PRESIDENT AND CHIEF OPERATING OFFICER AND BOARD MEMBER; ANDCONFERENCE CALL SCHEDULED FOR TUESDAY, DECEMBER 3RD  AT 9:30 AM CTACQUISITION OF FAIRFAX MEMORIAL PARK AND FUNERAL HOMEHOUSTON, Dec. 02, 2019 (GLOBE NEWSWIRE) — Mel Payne, Chairman and Chief Executive Officer of Carriage Services, Inc. (NYSE: CSV) (“Carriage” or the “Company”) stated, “I am excited and very honored to announce that we have signed a definitive agreement to acquire Fairfax Memorial Park and Funeral Home in Fairfax, Virginia, which was co-founded in 1957 by four men including Cornelius H. Doherty and his son Cornelius, Jr. (Neil), and today is led by Neil’s son, Michael (Mike) H. Doherty.  Fairfax Memorial Park was...

BROOKFIELD, NEWS, Dec. 02, 2019 (GLOBE NEWSWIRE) — Brookfield Asset Management Inc. (TSX: BAM.A, NYSE: BAM) (“Brookfield”) today announced that it has determined the quarterly dividend on its floating rate Cumulative Class A Preference Shares, Series 25 (“Series 25 Shares”) (TSX: BAM.PR.S).The dividend on the Series 25 Shares is paid at an annual rate, calculated for each quarter, of 2.30% over the annual yield on three-month Government of Canada treasury bills. The actual quarterly dividend rate in respect of the January 1, 2020 to March 31, 2020 dividend period will be 0.98529% (3.952% on an annualized basis) and the dividend, if declared, for such dividend period will be $0.2463225 per share, payable on March 31, 2020.Brookfield Asset Management Inc. is a leading global alternative asset manager with over $500 billion of assets...